EP2856149
LÍFMERKI FYRIR SYKURSÝKI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.5.2013EP published:
8.7.2020EP application number:
13794110.0
EP translation filed:
7.8.2020Grant published:
15.9.2020EPO information:
European Patent Register
Max expiry date:
23.5.2033Expiry date:
23.5.2026Next due date:
31.5.2026
Title:
DIABETES BIOMARKERS
Timeline
Today
24.5.2013EP application
8.7.2020EP Publication
7.8.2020Translation submitted
15.9.2020Registration published
23.5.2026Expires
Owner
Name:
Phaim Pharma LtdAddress:
One Bartholomew Close, EC1A 7BL, London, GB
Inventor
Name:
ORBAN, TihamerAddress:
Brookline, MA 02446, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261651144 PDate:
24.5.2012Country:
US
Classification
Categories:
G01N 33/48, G01N 33/564
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 21.5.2021
Expires: 23.5.2022
Payer: CPA Global (Patrafee) AB
Number: 10
Paid: 24.5.2022
Expires: 23.5.2023
Payer: CPA Global (Patrafee) AB
Number: 11
Paid: 31.5.2023
Expires: 23.5.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 28.11.2024
Expires: 23.5.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 23.5.2025
Expires: 23.5.2026
Payer: CPA Global (Patrafee) AB